| Jacqueline S Orender Do Llc | |
|
2305 S. Tucker Terrace Pittsburg KS 66762-6623 | |
| (620) 231-3132 | |
| (620) 231-3133 |
| Full Name | Jacqueline S Orender Do Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 2305 S. Tucker Terrace, Pittsburg, Kansas |
| Authorized Official Name and Position | Jacqueline S Orender (OWNER/PHYSICIAN) |
| Authorized Official Contact | 6202313132 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline S Orender Do Llc 2305 S. Tucker Terrace Pittsburg KS 66762-2026 Ph: (620) 231-3132 | Jacqueline S Orender Do Llc 2305 S. Tucker Terrace Pittsburg KS 66762-6623 Ph: (620) 231-3132 |
| NPI Number | 1184955023 |
|---|---|
| Provider Enumeration Date | 01/15/2010 |
| Last Update Date | 02/22/2011 |
| Medicare PECOS PAC ID | 7012052657 |
|---|---|
| Medicare Enrollment ID | O20100306000170 |
News Archive
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184955023 | NPI | - | NPPES |
| 0529686 | Other | KS | KANSAS LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0529686 (Kansas) | Primary |
| Provider Name | Jacqueline S Orender |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174559520 PECOS PAC ID: 9335157213 Enrollment ID: I20060404000521 |
News Archive
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
› Verified 2 days ago
| Provider Name | Lauren E Mendicki |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275098873 PECOS PAC ID: 6901134394 Enrollment ID: I20220909000619 |
News Archive
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
› Verified 2 days ago
News Archive
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
› Verified 2 days ago
Trifitness 247 Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2609 N Broadway St Ste A, Pittsburg, KS 66762 Phone: 620-404-5155 | |
Rick D. Schoeling, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2501 S Springdale St, Pittsburg, KS 66762 Phone: 620-232-9090 Fax: 620-235-0215 | |
Haskell Regional Hospital, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2707 N Broadway St Ste A, Pittsburg, KS 66762 Phone: 620-979-9470 Fax: 620-979-9468 | |
Community Health Center Of Southeast Kansas, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 924 N Broadway St, Pittsburg, KS 66762 Phone: 620-231-6788 Fax: 620-231-2331 | |
Labette County Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2309 S Tucker Ter, Pittsburg, KS 66762 Phone: 620-291-1101 Fax: 877-490-6696 | |
St. John's Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2711 S Rouse St, Suite C, Pittsburg, KS 66762 Phone: 417-627-8967 Fax: 417-627-8951 |